Indaptus Therapeutics, INC. (INDP) SEC Filings — 2024
17 SEC filings for Indaptus Therapeutics, INC. (INDP) in 2024.
Filings
- Indaptus Therapeutics Files S-1 with SEC — S-1 · Dec 23, 2024
- Meckler Amends Indaptus Therapeutics Stake Filing — SC 13D/A · Nov 26, 2024
- Indaptus Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Nov 22, 2024
- Indaptus Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Indaptus Therapeutics Terminates Merger with 03 Life Sciences — 8-K · Oct 22, 2024
- Meckler Files SC 13D for Indaptus Therapeutics — SC 13D · Oct 10, 2024
- Indaptus Therapeutics Files S-1 for Security Registration — S-1 · Sep 12, 2024
- Indaptus Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Indaptus Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Aug 8, 2024
- Indaptus Therapeutics Holds Annual Meeting, Elects Directors — 8-K · Jun 7, 2024
- Indaptus Therapeutics Files 8-K — 8-K · May 22, 2024
- Indaptus Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Indaptus Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Indaptus Therapeutics to be Acquired by 03 Life Sciences — 8-K · Mar 25, 2024
- Indaptus Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 13, 2024
- Indaptus Therapeutics Relocates HQ — 8-K · Mar 4, 2024
- Indaptus Therapeutics Files Routine 8-K; No Major Changes Reported — 8-K · Jan 23, 2024